Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Subscribe To Our Newsletter & Stay Updated
